The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Nuclear Proteins

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Nuclear Proteins.
Olatoyosi Odenike
Connection Strength
0.197
Nuclear Proteins
  1. Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML. J Clin Oncol. 2025 Aug 10; 43(23):2606-2615.
    View in: PubMed
    Score: 0.165
  2. Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. Mol Cell. 2021 09 16; 81(18):3833-3847.e11.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.